Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cyrielle Caussy

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
Diabetes & Metabolism|August 5, 2020
Non-alcoholic fatty liver disease and chronic kidney disease: renal benefit with liver stiffness assessment?Cyrielle Caussy
Alimentary Pharmacology & Therapeutics|April 24, 2023
Editorial: improvement of cardiovascular risk factor control in patients with type 2 diabetes and nonalcoholic fatty liver disease-time for action!Cyrielle Caussy
Gut|October 24, 2024
Treatment of type 2 diabetes with MASLD: new evidence for personalised medicineCyrielle Caussy
Alimentary Pharmacology & Therapeutics|April 16, 2022
Editorial: screening for hepatocellular carcinoma in NAFLD-towards abbreviated MRI alternative in patients with obesity?Fanny Lebossé, Cyrielle Caussy
Nature Reviews. Gastroenterology & Hepatology|August 31, 2018
Gut microbiome, microbial metabolites and the development of NAFLDCyrielle Caussy, Rohit Loomba
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 20, 2019
ReplyCyrielle Caussy, Rohit Loomba
Endocrinology, Diabetes & Metabolism|October 26, 2020
Magnetic resonance-based biomarkers in nonalcoholic fatty liver disease and nonalcoholic steatohepatitisCyrielle Caussy, Lars Johansson
JHEP Reports : Innovation in Hepatology|March 11, 2026
Management of obesity in advanced chronic liver diseaseCyrielle Caussy, Sven M Francque
Current Diabetes Reports|March 20, 2021
The Relationship Between Type 2 Diabetes, NAFLD, and Cardiovascular RiskCyrielle Caussy, Adrien Aubin, Rohit Loomba
Med (New York, N.Y.)|June 3, 2026
The thyroid-liver axis in MASLD: From metabolic control to clinical translationYasmina Chouik, Cyrielle Caussy, Frank Tacke
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Diabetes & Metabolism|August 5, 2020
Non-alcoholic fatty liver disease and chronic kidney disease: renal benefit with liver stiffness assessment?Cyrielle Caussy
Alimentary Pharmacology & Therapeutics|April 24, 2023
Editorial: improvement of cardiovascular risk factor control in patients with type 2 diabetes and nonalcoholic fatty liver disease-time for action!Cyrielle Caussy
Gut|October 24, 2024
Treatment of type 2 diabetes with MASLD: new evidence for personalised medicineCyrielle Caussy
Alimentary Pharmacology & Therapeutics|April 16, 2022
Editorial: screening for hepatocellular carcinoma in NAFLD-towards abbreviated MRI alternative in patients with obesity?Fanny Lebossé, Cyrielle Caussy
Nature Reviews. Gastroenterology & Hepatology|August 31, 2018
Gut microbiome, microbial metabolites and the development of NAFLDCyrielle Caussy, Rohit Loomba
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 20, 2019
ReplyCyrielle Caussy, Rohit Loomba
Endocrinology, Diabetes & Metabolism|October 26, 2020
Magnetic resonance-based biomarkers in nonalcoholic fatty liver disease and nonalcoholic steatohepatitisCyrielle Caussy, Lars Johansson
JHEP Reports : Innovation in Hepatology|March 11, 2026
Management of obesity in advanced chronic liver diseaseCyrielle Caussy, Sven M Francque
Current Diabetes Reports|March 20, 2021
The Relationship Between Type 2 Diabetes, NAFLD, and Cardiovascular RiskCyrielle Caussy, Adrien Aubin, Rohit Loomba
Med (New York, N.Y.)|June 3, 2026
The thyroid-liver axis in MASLD: From metabolic control to clinical translationYasmina Chouik, Cyrielle Caussy, Frank Tacke
Pageof 9